United-Guardian FY 2024 net sales +12% to $12.18M; EPS $0.71 vs $0.56

UNITED GUARDIAN INC

Net income $3.25M ($0.71 per share) vs $2.58M ($0.56) in FY 2023.
Cosmetics ingredients sales surged 32%; medical lubricants up 16%.
Pharmaceutical sales fell 5% due to Renacidin supply disruption into Q1 2024.
Management expects Renacidin sales to recover to prior levels in 2025.
Growth driven by increased demand from largest distributor and Chinese accounts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.